Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMERALD: EO2002 in Corneal Edema Secondary to Corneal Endothelial Dysfunction
NCT07729137Phase 2Recruiting
- Sponsor
- Emmetrope Ophthalmics LLC
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of EO2002 in corneal edema, sponsored by Emmetrope Ophthalmics LLC. Started Oct 2026; status: recruiting.
02
Drugs
EO2002
03
Conditions
corneal edema
Beyond the preview
Go deeper on NCT07729137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07729137.